标题
High-Dose Cytarabine (HD araC) in the Treatment of Leukemias: a Review
作者
关键词
Cytosine arabinoside, araC, HD araC, High-dose cytarabine, Leukemia, AML, Acute myeloid leukemia
出版物
Current Hematologic Malignancy Reports
Volume 8, Issue 2, Pages 141-148
出版商
Springer Nature
发表日期
2013-05-11
DOI
10.1007/s11899-013-0156-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
- (2011) Eric Tse et al. ANNALS OF HEMATOLOGY
- Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study
- (2011) X. Thomas et al. BLOOD
- Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia
- (2011) Pamela S. Becker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
- (2011) Caicun Zhou et al. LANCET ONCOLOGY
- A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study
- (2010) S. Miyawaki et al. BLOOD
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse
- (2010) S. Kurosawa et al. HAEMATOLOGICA
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission
- (2009) John Koreth et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin
- (2009) P Chevallier et al. LEUKEMIA
- Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic Cells
- (2008) J. Cai et al. CANCER RESEARCH
- Patients With Acute Myeloid Leukemia andRASMutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study
- (2008) Andreas Neubauer et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
- (2008) Richard F. Schlenk et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started